Vibrating Mesh Membrane (Nebulizer)

Japanese healthcare equipment company (OMRON Corporation subsidiary; HQ Muko, Kyoto Prefecture; OMRON Corporation TSE: 6645); makes mesh nebulizers (MicroAIR NE-U22 series) and manufactures vibrating mesh membranes in-house using precision photo-etching and electroforming processes at its Japanese manufacturing facilities. OMRON Healthcare is the world's leading mesh nebulizer manufacturer by volume, and its MicroAIR technology uses titanium or stainless steel mesh membranes with 2,700-6,000 holes of 2.1-5.7 μm diameter, produced using semiconductor-grade precision etching processes. OMRON is a Japanese industrial conglomerate whose products span: industrial automation robots (the largest revenue segment), healthcare monitors (blood pressure monitors, thermometers, glucose meters), and drug delivery devices (nebulizers). The same OMRON that makes blood pressure cuffs sold at CVS also makes the precision titanium mesh through which albuterol passes in a hospital ICU nebulizer therapy session.

German respiratory medical device company (HQ Starnberg, Bavaria; private, founded 1906); a specialist inhaler and nebulizer manufacturer whose eFlow® technology (LC Sprint nebulizer, eFlow rapid) uses vibrating perforated membranes to generate pharmaceutical aerosols without heating the drug. PARI's eFlow mesh nebulizers are used for inhalation of antibiotics (tobramycin for cystic fibrosis — Cayston via Altera nebulizer), colistin, and experimental therapies where drug stability limits pMDI use. PARI manufactures its vibrating mesh membranes through European precision metalworking partnerships. PARI was founded in 1906 (pre-World War I) in Munich as an atomizer manufacturer — making it one of the oldest respiratory drug delivery device companies in the world. PARI's nebulizers are the device of choice for cystic fibrosis patients requiring daily antibiotic inhalation therapy — a demanding use case where mesh membrane longevity and aerosol consistency are life-critical.

Dutch healthcare technology company (Euronext: PHIA, HQ Amsterdam; ~$18B revenue); Respironics division (acquired from Respironics Inc. 2008) produces mesh nebulizers (InnoSpire Go, SideStream) as part of its respiratory care portfolio. Philips Respironics was severely damaged by the 2021 recall of ~4 million CPAP machines (Continuous Positive Airway Pressure for sleep apnea) due to sound abatement foam that was found to degrade into potentially carcinogenic particles — the largest medical device recall in US history by value (~$1.5B settlement, regulatory sanctions, CEO resignation). The Philips CPAP recall, while unrelated to its nebulizer products, significantly damaged the company's reputation, financial position, and regulatory standing — creating uncertainty about its nebulizer product line continuity. A CPAP foam degradation problem in sleep apnea devices created supply chain uncertainty for mesh nebulizers used by hospital COPD patients.